7th Antigen Specific Immune Tolerance Summit 2024
March
18

7th Antigen Specific Immune Tolerance Summit 2024

 March 18 to March 20, 2024 

Hilton Boston Back Bay, 40 Dalton Street, Boston, Massachusetts, 02115, United States


The highly anticipated 7th Antigen-Specific Immune Tolerance Drug Development Summit, taking place from Mon, 18 Mar 2024 to Wed, 20 Mar 2024, is a premier industry forum dedicated to showcasing the latest advancements in tolerogenic therapies. This pivotal event encompasses discoveries in preclinical and clinical development, emphasizing biomarkers and proof-of-concept studies. Immune tolerance strategies hold immense potential, not solely for treating but potentially curing autoimmune diseases. These approaches, such as those being pursued in Diamyd's phase III trial for type I diabetes, COUR, Anokion, Imcyse, Takeda, and Selecta's phase II trials, signify a promising shift away from standard immunosuppression therapies, heralding a transformative era in biopharma's quest to deliver efficacious antigen-specific treatments to patients in need.

Read on as-immunetolerance.com

Continue reading at

Related Offerings

Interested in this event?


Next Event

  • March
    18

    6th Edition of International Conference on Materials Science and Engineering (MATERIALS 2024)

     March 18 to March 20, 2024 

    Village Hotel Bugis 390 Victoria St, Singapore 188061

    6th Edition of International Conference on Materials Science and Engineering (MATERIALS 2024)

Medigy Innovation Network

Connecting innovation decision makers to authoritative information, institutions, people and insights.

Medigy Logo

The latest News, Insights & Events

Medigy accurately delivers healthcare and technology information, news and insight from around the world.

The best products, services & solutions

Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.


© 2024 Netspective Media LLC. All Rights Reserved.

Built on Feb 29, 2024 at 10:43am